<DOC>
	<DOCNO>NCT01050595</DOCNO>
	<brief_summary>The purpose study determine significantly high incidence bowel movement methylnaltrexone vs. placebo within 4 hour +- 45 minute decrease need rescue medication intensive care unit patient opioid-induced constipation . Patients also manage aggressive bowel management protocol .</brief_summary>
	<brief_title>Methylnaltrexone Treatment Opiate-Induced Constipation Intensive Care Unit</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Methylnaltrexone</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>18 year age old ICU Opioids analgesia least 24 hour . Opioidinduced constipation bowel movement within last 72 hour . Women childbearing potential negative pregnancy test . Contraindication use GI tract Diarrhea admission Bowel surgery within 8 week admission Ileostomy colostomy Not expect live stay 3 day intensive care unit Constipation primarily cause opioids ( determined investigator ) No opioid use last 24 hour , Mechanical gastrointestinal obstruction An indwelling peritoneal catheter Clinically active diverticular disease Fecal impaction Acute surgical abdomen History Crohn 's disease ulcerative colitis On Palliative care Less 18 year old Bowel movement last 72 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Constipation</keyword>
	<keyword>Bowel Management</keyword>
</DOC>